Biostar Pharmaceutical Provides Unaudited Preliminary Updates (BSPM)

Biostar Pharmaceutical BSPM announces unaudited October and November 2010 combined revenues increased 68% to approximately $18.3 million; Sales of Xin Aoxing increased 67% to $12.4 million. Biostar Pharmaceutical's rural distribution network surpasses 9,500 locations; on track to reach 10,000 by December 31, 2010.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidance
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!